When.com Web Search

  1. Ads

    related to: trilogy inhaler for copd

Search results

  1. Results From The WOW.Com Content Network
  2. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/...

    The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...

  3. Medicare Coverage for COPD Inhalers - AOL

    www.aol.com/lifestyle/medicare-coverage-copd...

    Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

  4. Ellipta - Wikipedia

    en.wikipedia.org/wiki/Ellipta

    Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler: Fluticasone furoate (Arnuity Ellipta, Relvar Ellipta) Fluticasone furoate/vilanterol (Breo Ellipta, Relvar Ellipta)

  5. Fluticasone furoate/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

    Fluticasone furoate/vilanterol, sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. [3] It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β 2 agonist (ultra-LABA). [3]

  6. AstraZeneca's Triple-Combo COPD Inhaler Gets CRL From FDA - AOL

    www.aol.com/news/astrazenecas-triple-combo-copd...

    For premium support please call: 800-290-4726 more ways to reach us

  7. AstraZeneca's Triple-Combo COPD Inhaler Gets China's Nod - AOL

    www.aol.com/news/astrazenecas-triple-combo-copd...

    AstraZeneca (AZN) gets approval in China for PT010, its triple-combo inhaler, a fixed-dose ICS/LABA/LAMA inhaler, to treat COPD.

  1. Ads

    related to: trilogy inhaler for copd